These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 15127235)

  • 21. Human rhinoviruses inhibit the accessory function of dendritic cells by inducing sialoadhesin and B7-H1 expression.
    Kirchberger S; Majdic O; Steinberger P; Blüml S; Pfistershammer K; Zlabinger G; Deszcz L; Kuechler E; Knapp W; Stöckl J
    J Immunol; 2005 Jul; 175(2):1145-52. PubMed ID: 16002716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B7-2 expression on tumor cells is important for the acquisition of cytotoxic T lymphocyte activity by spleen cells from low-dose-melphalan-treated MOPC-315 tumor bearers via a mechanism that requires either B7-1 or B7-2 expression on host antigen-presenting cells.
    Sojka DK; La Motte RN; Mokyr MB
    Cancer Immunol Immunother; 2000 Apr; 49(1):10-22. PubMed ID: 10782862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions [corrections].
    Taylor PA; Lees CJ; Fournier S; Allison JP; Sharpe AH; Blazar BR
    J Immunol; 2004 Jan; 172(1):34-9. PubMed ID: 14688306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of reduced T-cell effector functions and class-switched antibody responses to herpes simplex virus type 2 in the absence of B7 costimulation.
    Thebeau LG; Morrison LA
    J Virol; 2003 Feb; 77(4):2426-35. PubMed ID: 12551980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-10 inhibits the immune stimulatory potential of melanoma cells retrovirally transduced with human B7.1 or B7.2.
    Geertsen R; Yue FY; Pavlovic J; Laine E; Dummer R
    Adv Exp Med Biol; 1998; 451():179-88. PubMed ID: 10026870
    [No Abstract]   [Full Text] [Related]  

  • 26. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
    Hussain S; Delovitch TL
    J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transfection of the gene for B7-1 but not B7-2 can induce immunity to murine malignant mesothelioma.
    Leong CC; Marley JV; Loh S; Milech N; Robinson BW; Garlepp MJ
    Int J Cancer; 1997 May; 71(3):476-82. PubMed ID: 9139887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen.
    Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
    J Immunol; 2003 Mar; 170(6):2912-22. PubMed ID: 12626542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites.
    Kobori H; Hashiguchi M; Piao J; Kato M; Ritprajak P; Azuma M
    Immunology; 2010 Jul; 130(3):363-73. PubMed ID: 20141543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NKG2D-mediated antitumor activity by tumor-infiltrating lymphocytes and antigen-specific T-cell clones isolated from melanoma patients.
    Maccalli C; Nonaka D; Piris A; Pende D; Rivoltini L; Castelli C; Parmiani G
    Clin Cancer Res; 2007 Dec; 13(24):7459-68. PubMed ID: 18094430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The requirements for CTL-mediated rejection of cancer in humans: NKG2D and its role in the immune responsiveness of melanoma.
    Wang E; Selleri S; Marincola FM
    Clin Cancer Res; 2007 Dec; 13(24):7228-31. PubMed ID: 18094399
    [No Abstract]   [Full Text] [Related]  

  • 32. NK cell triggering by the human costimulatory molecules CD80 and CD86.
    Wilson JL; Charo J; Martín-Fontecha A; Dellabona P; Casorati G; Chambers BJ; Kiessling R; Bejarano MT; Ljunggren HG
    J Immunol; 1999 Oct; 163(8):4207-12. PubMed ID: 10510357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sister cytotoxic CD8+ T cell clones differing in natural killer inhibitory receptor expression in human astrocytoma.
    Perrin G; Speiser D; Porret A; Quiquerez AL; Walker PR; Dietrich PY
    Immunol Lett; 2002 Apr; 81(2):125-32. PubMed ID: 11852117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.
    Poccia F; Cipriani B; Vendetti S; Colizzi V; Poquet Y; Battistini L; López-Botet M; Fournié JJ; Gougeon ML
    J Immunol; 1997 Dec; 159(12):6009-17. PubMed ID: 9550399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of MHC class-I restricted TCRalphabeta+ CD4- CD8- double negative T cells recognizing the gp100 antigen from a melanoma patient after gp100 vaccination.
    Voelkl S; Moore TV; Rehli M; Nishimura MI; Mackensen A; Fischer K
    Cancer Immunol Immunother; 2009 May; 58(5):709-18. PubMed ID: 18836718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.
    Hathcock KS; Laszlo G; Pucillo C; Linsley P; Hodes RJ
    J Exp Med; 1994 Aug; 180(2):631-40. PubMed ID: 7519245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intercellular adhesion molecule 1 is critical for activation of CD28-deficient T cells.
    Gaglia JL; Greenfield EA; Mattoo A; Sharpe AH; Freeman GJ; Kuchroo VK
    J Immunol; 2000 Dec; 165(11):6091-8. PubMed ID: 11086041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction.
    Rivoltini L; Carrabba M; Huber V; Castelli C; Novellino L; Dalerba P; Mortarini R; Arancia G; Anichini A; Fais S; Parmiani G
    Immunol Rev; 2002 Oct; 188():97-113. PubMed ID: 12445284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complex interplay of activating and inhibitory signals received by Vgamma9Vdelta2 T cells revealed by target cell beta2-microglobulin knockdown.
    Trichet V; Benezech C; Dousset C; Gesnel MC; Bonneville M; Breathnach R
    J Immunol; 2006 Nov; 177(9):6129-36. PubMed ID: 17056540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of inhibitory receptors Ly49E and CD94/NKG2 on fetal thymic and adult epidermal TCR V gamma 3 lymphocytes.
    Van Beneden K; De Creus A; Stevenaert F; Debacker V; Plum J; Leclercq G
    J Immunol; 2002 Apr; 168(7):3295-302. PubMed ID: 11907085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.